Search research articles
Contact Us
Filters
Showing results (111-120 of 409) with videos related to
Page
of 41
Sort By:
Nature Reviews. Neurology
|
October 15, 2009
Pediatric multiple sclerosis
E Ann Yeh, Tanuja Chitnis, Lauren Krupp, et al.
Neurology
|
August 31, 2016
Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases
Amit Bar-Or, Rogier Q Hintzen, Russell C Dale, et al.
Journal of the Neurological Sciences
|
February 5, 2026
Correlation between blood biomarkers and patient-reported outcomes (PROs) of depression and mental health scores in individuals with multiple sclerosis (iwMS)
Moogeh Baharnoori, Bonnie Glanz, Mariann Polgar-Turcsanyi, et al.
Multiple Sclerosis and Related Disorders
|
August 3, 2019
Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes
Hajime Yano, Cindy Gonzalez, Brian C Healy, et al.
Archives of Neurology
|
January 11, 2012
Daclizumab use in patients with pediatric multiple sclerosis
Mark P Gorman, Jan-Mendelt Tillema, Annika M Ciliax, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 24, 2018
Diet quality and risk of multiple sclerosis in two cohorts of US women
Dalia L Rotstein, Marianna Cortese, Teresa T Fung, et al.
JAMA Neurology
|
October 26, 2020
Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society
Aaron E Miller, Tanuja Chitnis, Bruce A Cohen, et al.
Neurology. Genetics
|
August 10, 2016
Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset
Riley Bove, Alicia S Chua, Zongqi Xia, et al.
JAMA Network Open
|
November 16, 2021
Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis
Jue Hou, Nicole Kim, Tianrun Cai, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 2, 2024
Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study
Tanuja Chitnis, Douglas L Arnold, Pierre Quartier, et al.
Page
of 41
Search research articles
Search
Showing results (111-120 of 409) with videos related to
Sort By:
Page
of 41
Nature Reviews. Neurology
|
October 15, 2009
Pediatric multiple sclerosis
E Ann Yeh, Tanuja Chitnis, Lauren Krupp, et al.
Neurology
|
August 31, 2016
Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases
Amit Bar-Or, Rogier Q Hintzen, Russell C Dale, et al.
Journal of the Neurological Sciences
|
February 5, 2026
Correlation between blood biomarkers and patient-reported outcomes (PROs) of depression and mental health scores in individuals with multiple sclerosis (iwMS)
Moogeh Baharnoori, Bonnie Glanz, Mariann Polgar-Turcsanyi, et al.
Multiple Sclerosis and Related Disorders
|
August 3, 2019
Discontinuation of disease-modifying therapy for patients with relapsing-remitting multiple sclerosis: Effect on clinical and MRI outcomes
Hajime Yano, Cindy Gonzalez, Brian C Healy, et al.
Archives of Neurology
|
January 11, 2012
Daclizumab use in patients with pediatric multiple sclerosis
Mark P Gorman, Jan-Mendelt Tillema, Annika M Ciliax, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 24, 2018
Diet quality and risk of multiple sclerosis in two cohorts of US women
Dalia L Rotstein, Marianna Cortese, Teresa T Fung, et al.
JAMA Neurology
|
October 26, 2020
Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society
Aaron E Miller, Tanuja Chitnis, Bruce A Cohen, et al.
Neurology. Genetics
|
August 10, 2016
Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset
Riley Bove, Alicia S Chua, Zongqi Xia, et al.
JAMA Network Open
|
November 16, 2021
Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis
Jue Hou, Nicole Kim, Tianrun Cai, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 2, 2024
Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study
Tanuja Chitnis, Douglas L Arnold, Pierre Quartier, et al.
Page
of 41